[go: up one dir, main page]

IN2013MU00848A - - Google Patents

Info

Publication number
IN2013MU00848A
IN2013MU00848A IN848MU2013A IN2013MU00848A IN 2013MU00848 A IN2013MU00848 A IN 2013MU00848A IN 848MU2013 A IN848MU2013 A IN 848MU2013A IN 2013MU00848 A IN2013MU00848 A IN 2013MU00848A
Authority
IN
India
Prior art keywords
anagliptin
intermediates
preparation
present
provides process
Prior art date
Application number
Inventor
Mahadev Kadam Suresh
Parsottam Kansagra Bipin
Nilkanth Bhadane Shailendra
Prakashrao Patil Jayant
Kantilal Kale Shrikrishna
Original Assignee
Glenmark Generics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glenmark Generics Ltd filed Critical Glenmark Generics Ltd
Priority to IN848MU2013 priority Critical patent/IN2013MU00848A/en
Priority to PCT/IN2014/000132 priority patent/WO2014147640A2/en
Publication of IN2013MU00848A publication Critical patent/IN2013MU00848A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The present invention provides process for the preparation of anagliptin and intermediates thereof.
IN848MU2013 2013-03-19 2014-02-28 IN2013MU00848A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IN848MU2013 IN2013MU00848A (en) 2013-03-19 2014-02-28
PCT/IN2014/000132 WO2014147640A2 (en) 2013-03-19 2014-02-28 Process for the preparation of anagliptin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN848MU2013 IN2013MU00848A (en) 2013-03-19 2014-02-28

Publications (1)

Publication Number Publication Date
IN2013MU00848A true IN2013MU00848A (en) 2015-05-01

Family

ID=51581562

Family Applications (1)

Application Number Title Priority Date Filing Date
IN848MU2013 IN2013MU00848A (en) 2013-03-19 2014-02-28

Country Status (2)

Country Link
IN (1) IN2013MU00848A (en)
WO (1) WO2014147640A2 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103896951A (en) * 2014-03-26 2014-07-02 上海朴颐化学科技有限公司 Synthetic method of 2-methyl-pyrazolo-[1,5-a]-pyrimidine-6-carboxylic acid
CN105315284A (en) * 2014-07-23 2016-02-10 上海医药工业研究院 Preparation method of Anagliptin intermediate
CN108358935A (en) * 2018-03-12 2018-08-03 南安市创培电子科技有限公司 A kind of synthetic method of medicine intermediate 2- methyl pyrazoles simultaneously [1,5-A] pyrimidine -6- carboxylic acids
CN108341782A (en) * 2018-03-30 2018-07-31 南京哈柏医药科技有限公司 The synthesis technology of 3- amino-5-methylpyrazoles
LT3773589T (en) 2018-04-03 2024-02-12 Blueprint Medicines Corporation A RET INHIBITOR FOR THE TREATMENT OF CANCER WITH A RET Mutation
CN110003218B (en) * 2019-03-26 2020-07-31 杭州瀚康生物医药科技有限公司 Preparation method of Allagliptin intermediate
WO2021136491A1 (en) * 2019-12-31 2021-07-08 石药集团中奇制药技术（石家庄）有限公司 Crystalline form of dipeptidyl peptidase iv inhibitor and preparation method therefor and use thereof
EP4157829A1 (en) 2020-05-29 2023-04-05 Blueprint Medicines Corporation Solid forms of pralsetinib
EP4255892A1 (en) 2020-12-04 2023-10-11 Blueprint Medicines Corporation Method of preparing pralsetinib
CN115650984A (en) * 2022-09-07 2023-01-31 江苏君若药业有限公司 Preparation method of anagliptin

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1595866T (en) * 2003-01-31 2016-09-14 Sanwa Kagaku Kenkyusho Co Cyanopyrrolidines useful for the treatment of inter alia metabolic syndrome

Also Published As

Publication number Publication date
WO2014147640A2 (en) 2014-09-25
WO2014147640A3 (en) 2015-02-26

Similar Documents

Publication Publication Date Title
PH12018500711A1 (en) Anti-pd1 antibodies and methods of use
PH12017500877B1 (en) ANTI-CD79b ANTIBODIES AND METHODS OF USE
MX2015012326A (en) Anti-crth2 antibodies and their use.
MY202415A (en) Subcutaneous formulations of anti-cd38 antibodies and their uses
MY176285A (en) Anti-fcrh5 antibodies
PH12016501763B1 (en) Multispecific antibodies
PH12014502132A1 (en) Anti-lgr5 antibodies and immunoconjugates
PH12014501605A1 (en) Anti-lrp5 antibodies and methods of use
SI3380530T1 (en) An improved process for the preparation of sugammadex and its intermediates
MY176855A (en) Anti-jagged1 antibodies and methods of use
IN2013MU00848A (en)
MX2014002053A (en) Anti-mcsp antibodies.
MX354303B (en) Anti-biotin antibodies and methods of use.
IN2012MU03723A (en)
IN2013MU00646A (en)
IN2015DE00625A (en)
IN2014DN09450A (en)
MX2020007742A (en) Processes for preparing fluoroketolides.
IN2013MU01113A (en)
PH12016501201A1 (en) Synthesis of ent-progesterone and intermediates thereof
MX2016004573A (en) Nsp4 inhibitors and methods of use.
PH12017500499A1 (en) Synthesis of ent-progesterone and intermediates thereof
NZ721832A (en) Solid forms of tenofovir
IL253077A0 (en) Process and intermediates for the preparation of perampanel
MX2015012902A (en) Synthesis of ent-progesterone and intermediates thereof.